A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Recent Filings
- 8-K102.0 KBANADYS PHARMACEUTICALS INCJan 24, 5:12 PM ET·0001299933-11-000231
- 47.3 KBANADYS PHARMACEUTICALS INCJan 5, 6:44 PM ET·0001181431-11-002006
- 410.6 KBANADYS PHARMACEUTICALS INCJan 3, 6:04 PM ET·0001181431-11-000429
- SC 13D117.1 KBANADYS PHARMACEUTICALS INCJan 3, 5:23 PM ET·0001193125-11-000442
- SC 13G/A109.9 KBANADYS PHARMACEUTICALS INCFeb 2, 10:27 AM ET·0001193125-10-018972
- 8-K51.5 KBANADYS PHARMACEUTICALS INCApr 30, 4:14 PM ET·0001299933-08-002245
- 8-K14.3 KBANADYS PHARMACEUTICALS INCDec 20, 5:01 PM ET·0001299933-07-007376
- 8-K54.4 KBANADYS PHARMACEUTICALS INCNov 1, 4:32 PM ET·0001299933-07-006329
- 45.0 KBANADYS PHARMACEUTICALS INCSep 14, 6:58 PM ET·0001209191-07-053567
- 8-K/A12.2 KBANADYS PHARMACEUTICALS INCAug 29, 5:24 PM ET·0001299933-07-005153
Insiders
10- Appleman James R.SVP, Research & CSO
- Eastwood Kevin L.SVP, Corporate Development
- FISHERMAN JASON SDirector
- FOLETTA MARK GDirector
- Freddo James LDirector, SVP, Drug Development and CMO
- Gallagher Carol GiltnerVP, Corp. Dev. & Comm. Affairs
- GLOVER JAMES TSVP, Operations and CFO
- HBM BIOVENTURES AG10% Owner
- Holtzman Steven HDirector
- KARABELAS ARGERIS NDirector
Tickers
No tickers on record
Addresses
business
5871 OBERLIN DRIVE, SUITE 200
SAN DIEGO, CA, 92121
mailing
5871 OBERLIN DRIVE, SUITE 200
SAN DIEGO, CA, 92121